There were no adverse events attributed to the procedure, which triggered a one hundred pc lessen in unbound N-terminal tau fragments in CSF. There were no effects on exploratory measures of disease severity.During this assay, researchers increase extracts from Alzheimer’s brain to cultured cells that incorporate fluorescently labeled tau fragmen